Spring House, PA (November 13, 2012) -- Clinlogix, a clinical research organization located just outside Philadelphia, is proud to announce its selection by the UPstart program at the University of Pennsylvania (“Penn”) as a preferred Clinical Research Organization. The UPstart program strives to maximize the potential of Penn research and technologies through the creation and stimulus of entrepreneurial endeavors. Clinlogix is extremely excited about this partnership, which allows the company to leverage its extensive clinical and regulatory experience and transfer that knowledge to a variety of UPSTART projects.
Michael Poisel, UPstart Director, stated that “So much of the success of our UPstart companies is determined by the involvement of our many partners along the way. We are excited to have the Clinlogix team join us and add their significant experience in the development of these exciting young businesses.”
JeanMarie Markham, President and CEO of Clinlogix, stated that “The relevance of this relationship is the recognition that early stage, academic research is beginning to think beyond its borders. Historically there have been challenges in the process of ‘translating’ academic research and concepts into a ‘commercial’ product and viable company. The selection of Clinlogix by UPstart reflects the organization’s forward thinking. UPstart is beginning with the end in mind. With limited financial resources, the goal is to make the most impact by developing viable strategic development plans. “
Clinlogix, a clinical research organization, provides comprehensive clinical development services for pharmaceutical, biotech and medical device companies engaged in clinical programs. A global service provider founded in 1999, Clinlogix supports and provides services for the successful clinical development of drugs, biologics, devices and diagnostics from Discovery and Phase I, through Phase IV and post-marketing of clinical trials, complying with worldwide regulatory requirements. Certified by the Women’s Business Enterprise National Council, Clinlogix succeeds in delivering quality and compliant results, on time and on budget. For more information, please visit http://www.clinlogix.com/.
The University of Pennsylvania, through its Center for Technology Transfer (CTT), works closely with faculty and staff to commercialize intellectual property developed at Penn. UPstart, a program managed by CTT, acts in partnership with Penn faculty, staff, and students to form and launch new companies based on selected inventions and innovative technologies. UPstart provides the Penn community with access to a wide range of company formation activities and support services, which include: addressable market analysis, development of marketing materials, fund-raising strategies, management team recruitment, partnership development, and commercialization grant preparation. For more information, please visit http://www.ctt.upenn.edu/upstart.html.